ABEONA THERAPEUTICS INC (ABEO) Stock Balance Sheet
NASDAQ:ABEO - Nasdaq - US00289Y2063 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 15.94M | 23.36M | 14.47M | 14.20M | 32.90M | |||
| Marketable Securities | 68.22M | 74.36M | 37.75M | 37.90M | 12.10M | |||
| Receivables | 1.62M | 1.65M | 2.44M | 200.00K | 3.00M | |||
| Other Current Assets | 2.35M | 1.48M | 1.07M | 700.00K | 7.40M | |||
| Total Current Assets | 88.12M | 100.85M | 55.74M | 53.10M | 55.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.19M | 7.98M | 7.99M | 11.10M | 21.70M | |||
| Goodwill | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | N/A | N/A | N/A | 0.00 | 1.40M | |||
| Other Non-Current Assets | 57.00K | 96.00K | 277.00K | 0.00 | 1.10M | |||
| Total Non-Current Assets | 11.24M | 8.08M | 8.26M | 11.10M | 24.20M | |||
| TOTAL ASSETS | 99.36M | 108.93M | 64.00M | 64.20M | 79.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 8.15M | 5.93M | N/A | N/A | 0.00 | |||
| Accrued Expenses | 4.50M | 7.16M | 6.98M | 5.80M | 7.40M | |||
| Accounts Payable | 5.02M | 3.44M | 1.86M | 1.80M | 4.30M | |||
| Other Current Liabilities | 317.00K | 64.00K | 4.58M | 200.00K | 4.90M | |||
| Total Current Liabilities | 17.98M | 16.59M | 13.42M | 7.80M | 16.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 11.14M | 13.04M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 28.85M | 35.28M | 35.75M | 29.70M | 11.60M | |||
| Total Non-Current Liabilities | 39.98M | 48.31M | 35.75M | 29.70M | 11.60M | |||
| TOTAL LIABILITIES | 57.97M | 64.90M | 49.18M | 37.50M | 28.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -825.29M | -813.26M | -749.52M | -695.30M | -655.60M | |||
| Additional Paid In Capital | 866.26M | 856.82M | 764.15M | 722.00M | 705.60M | |||
| Common Shares | 490.00K | 457.00K | 265.00K | 200.00K | 1.50M | |||
| Other Shareholders' Equity | -67.00K | 8.00K | -66.00K | -100.00K | 0.00 | |||
| Shares Outstanding | 48.95M | 45.64M | 26.52M | 17.70M | 5.90M | |||
| Tangible Book Value per Share | 0.85 | 0.96 | 0.56 | 1.51 | 8.47 | |||
| Total Shareholders' Equity | 41.40M | 44.03M | 14.83M | 26.80M | 51.40M | |||
| TOTAL LIABILITIES AND EQUITY | 99.36M | 108.93M | 64.00M | 64.20M | 79.60M | |||
| Statistics | ||||||||
| Debt/Equity | 0.27 | 0.30 | N/A | N/A | N/A | |||
| Current Ratio | 4.90 | 6.08 | 4.15 | 6.81 | 3.34 | |||
| Return On Assets (ROA) | -44.47% | -58.51% | -84.67% | -67.73% | -106.71% | |||
| Return On Equity (ROE) | -106.74% | -144.75% | -365.49% | -162.24% | -165.25% | |||
All data in USD , ROIC based on taxRate of 0.21